These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

433 related articles for article (PubMed ID: 26857072)

  • 21. A Biophysical Model of CRISPR/Cas9 Activity for Rational Design of Genome Editing and Gene Regulation.
    Farasat I; Salis HM
    PLoS Comput Biol; 2016 Jan; 12(1):e1004724. PubMed ID: 26824432
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Switchable Cas9.
    Richter F; Fonfara I; Gelfert R; Nack J; Charpentier E; Möglich A
    Curr Opin Biotechnol; 2017 Dec; 48():119-126. PubMed ID: 28456061
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Protein engineering of Cas9 for enhanced function.
    Oakes BL; Nadler DC; Savage DF
    Methods Enzymol; 2014; 546():491-511. PubMed ID: 25398355
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Application of machine learning in the CRISPR/Cas9 system].
    Zhang GS; Yang Y; Zhang LM; Dai XH
    Yi Chuan; 2018 Sep; 40(9):704-723. PubMed ID: 30369475
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The CRISPR-Cas system for plant genome editing: advances and opportunities.
    Kumar V; Jain M
    J Exp Bot; 2015 Jan; 66(1):47-57. PubMed ID: 25371501
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Single-Stranded DNA Cleavage by Divergent CRISPR-Cas9 Enzymes.
    Ma E; Harrington LB; O'Connell MR; Zhou K; Doudna JA
    Mol Cell; 2015 Nov; 60(3):398-407. PubMed ID: 26545076
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Genome engineering in ophthalmology: Application of CRISPR/Cas to the treatment of eye disease.
    Hung SSC; McCaughey T; Swann O; Pébay A; Hewitt AW
    Prog Retin Eye Res; 2016 Jul; 53():1-20. PubMed ID: 27181583
    [TBL] [Abstract][Full Text] [Related]  

  • 28. CRISPR/Cas9: a historical and chemical biology perspective of targeted genome engineering.
    Singh A; Chakraborty D; Maiti S
    Chem Soc Rev; 2016 Dec; 45(24):6666-6684. PubMed ID: 27711765
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Photoactivatable CRISPR-Cas9 for optogenetic genome editing.
    Nihongaki Y; Kawano F; Nakajima T; Sato M
    Nat Biotechnol; 2015 Jul; 33(7):755-60. PubMed ID: 26076431
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Selection and Validation of Spacer Sequences for CRISPR-Cas9 Genome Editing and Transcription Regulation in Bacteria.
    Grenier F; Lucier JF; Rodrigue S
    Methods Mol Biol; 2015; 1334():233-44. PubMed ID: 26404154
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Systematic analysis of CRISPR-Cas9 mismatch tolerance reveals low levels of off-target activity.
    Anderson EM; Haupt A; Schiel JA; Chou E; Machado HB; Strezoska Ž; Lenger S; McClelland S; Birmingham A; Vermeulen A; Smith Av
    J Biotechnol; 2015 Oct; 211():56-65. PubMed ID: 26189696
    [TBL] [Abstract][Full Text] [Related]  

  • 32. CRISPR/Cas9-mediated genome engineering: an adeno-associated viral (AAV) vector toolbox.
    Senís E; Fatouros C; Große S; Wiedtke E; Niopek D; Mueller AK; Börner K; Grimm D
    Biotechnol J; 2014 Nov; 9(11):1402-12. PubMed ID: 25186301
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Applications of Cas9 as an RNA-programmed RNA-binding protein.
    Nelles DA; Fang MY; Aigner S; Yeo GW
    Bioessays; 2015 Jul; 37(7):732-9. PubMed ID: 25880497
    [TBL] [Abstract][Full Text] [Related]  

  • 34. RNA-dependent DNA endonuclease Cas9 of the CRISPR system: Holy Grail of genome editing?
    Gasiunas G; Siksnys V
    Trends Microbiol; 2013 Nov; 21(11):562-7. PubMed ID: 24095303
    [TBL] [Abstract][Full Text] [Related]  

  • 35. RNA Interference in the Age of CRISPR: Will CRISPR Interfere with RNAi?
    Unniyampurath U; Pilankatta R; Krishnan MN
    Int J Mol Sci; 2016 Feb; 17(3):291. PubMed ID: 26927085
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Harnessing CRISPR-Cas systems for bacterial genome editing.
    Selle K; Barrangou R
    Trends Microbiol; 2015 Apr; 23(4):225-32. PubMed ID: 25698413
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The CRISPR/Cas9 system produces specific and homozygous targeted gene editing in rice in one generation.
    Zhang H; Zhang J; Wei P; Zhang B; Gou F; Feng Z; Mao Y; Yang L; Zhang H; Xu N; Zhu JK
    Plant Biotechnol J; 2014 Aug; 12(6):797-807. PubMed ID: 24854982
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Efficient RNA/Cas9-mediated genome editing in Xenopus tropicalis.
    Guo X; Zhang T; Hu Z; Zhang Y; Shi Z; Wang Q; Cui Y; Wang F; Zhao H; Chen Y
    Development; 2014 Feb; 141(3):707-14. PubMed ID: 24401372
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The application of genome editing in studying hearing loss.
    Zou B; Mittal R; Grati M; Lu Z; Shu Y; Tao Y; Feng Y; Xie D; Kong W; Yang S; Chen ZY; Liu X
    Hear Res; 2015 Sep; 327():102-8. PubMed ID: 25987504
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Efficiency and Inheritance of Targeted Mutagenesis in Maize Using CRISPR-Cas9.
    Zhu J; Song N; Sun S; Yang W; Zhao H; Song W; Lai J
    J Genet Genomics; 2016 Jan; 43(1):25-36. PubMed ID: 26842991
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.